Results 11 to 20 of about 86,047 (385)

Exposure to excess phenobarbital negatively influences the osteogenesis of chick embryos [PDF]

open access: yesFrontiers in Pharmacology, 2016
Phenobarbital is an antiepileptic drug that is widely used to treat epilepsy in a clinical setting. However, a long term of phenobarbital administration in pregnant women may produce side effects on embryonic skeletogenesis.
Yu Yan   +8 more
doaj   +5 more sources

Phenobarbital as alternate anticonvulsant for organophosphate‐induced benzodiazepine‐refractory status epilepticus and neuronal injury

open access: yesEpilepsia Open, 2020
Objective Organophosphates (OPs) such as diisopropylfluorophosphate (DFP) and soman are lethal chemical agents that can produce seizures, refractory status epilepticus (SE), and brain damage.
Doodipala Samba Reddy   +5 more
doaj   +2 more sources

Efficacy of phenobarbital is maintained after exposure to mild‐to‐moderate seizures in neonates [PDF]

open access: yesEpilepsia Open
To study the relationship between the delay in treatment and the efficacy of phenobarbital in neonates, we re‐analyzed data from the NEOLEV2 study. Continuous video EEG (cEEG) from patients treated with phenobarbital was reviewed by neurophysiologists ...
Cynthia Sharpe   +9 more
doaj   +2 more sources

Phenobarbital dyskinesia [PDF]

open access: bronzePostgraduate Medical Journal, 1978
Summary A patient was admitted to hospital following an overdose of phenobarbital. During her recovery she developed both chorea and torsion dystonia which could only be related to her high plasma phenobarbital levels.
S L Lightman
openalex   +4 more sources

A Comparison of Parenteral Phenobarbital vs. Parenteral Phenytoin as Second-Line Management for Pediatric Convulsive Status Epilepticus in a Resource-Limited Setting

open access: yesFrontiers in Neurology, 2019
Introduction: Pediatric convulsive status epilepticus (CSE) which is refractory to first-line benzodiazepines is a significant clinical challenge, especially within resource-limited countries.
Richard J. Burman   +8 more
doaj   +2 more sources

Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures [PDF]

open access: yesPLoS ONE, 2013
Neonatal seizures can be refractory to conventional anticonvulsants, and this may in part be due to a developmental increase in expression of the neuronal Na+-K+-2 Cl− cotransporter, NKCC1, and consequent paradoxical excitatory actions of GABAA receptors
Berry, Gerard T.   +11 more
core   +4 more sources

Phenobarbital: missing in action.

open access: yesBulletin of the World Health Organization, 2012
Epilepsy affects more than 60 million people worldwide, and over 80% of them live in resource-poor countries.1 Approximately 85% of these people do not receive appropriate treatment2 because of economic, cultural, social and legislative barriers ...
Neshan B Ilangaratne   +3 more
semanticscholar   +4 more sources

Phenobarbital versus benzodiazepines in alcohol withdrawal syndrome

open access: yesNeuropsychopharmacology Reports, 2023
Aim Phenobarbital, a long‐acting barbiturate, presents an alternative to conventional benzodiazepine treatment for alcohol withdrawal syndrome (AWS).
Deanna Malone   +5 more
doaj   +1 more source

Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial

open access: yesPediatrics, 2020
This phase IIb randomized controlled trial demonstrates greater efficacy of phenobarbital than levetiracetam in the treatment of neonatal seizures; more adverse events occurred with phenobarbital.
Cynthia Sharpe   +24 more
semanticscholar   +1 more source

Evaluation of Prophylactic and Therapeutic Effects of Silymarin on Phenobar- bital-Induced Hepatotoxicity in Cats [PDF]

open access: yesIranian Journal of Veterinary Medicine, 2020
BACKGROUND: Phenobarbital is one of the most commonly used drugs to treat epilepsy and other seizure disorders in dogs and cats. Hepatotoxicity following phenobarbital administration is dose-dependent.
Bahman Mosallanejad   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy